I am a hematologist/oncologist who specializes in the research and treatment of patients with a variety of myeloid malignancies. These include myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.
I currently spend the majority of my time in laboratory-based research investigating the underlying causes of these disorders through genomic studies of patient samples as well as in vitro and in vivo models. As a member of the laboratory of Ross Levine in the Human Oncology and Pathogenesis Program, I have helped to identify and characterize several new genetic abnormalities in the diseases mentioned above. In addition to increasing our understanding of the causes of these disorders, these discoveries have promise in helping to discover novel targeted therapies.